Funds · BCRX

Who owns BCRX?

Institutional ownership of BioCryst Pharmaceuticals Inc. from Form 13F, Q2 2026

318 institutional managers reported holding BioCryst Pharmaceuticals Inc. (BCRX) in Form 13F filings for Q2 2026, with 263,846,834 shares worth $2.6B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 15,679,274 shares (+6.6%). 54 opened new positions and 37 sold out.

Funds holding
318
Value held
$2.6B
New / sold out
54 / 37
Net shares, same filers
+6.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of BCRX

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$239M9.1%23,893,036Added
Ra Capital Management, L.p.$158M6.0%15,827,186Unchanged
State Street Corp$152M5.8%15,191,098Added
Deerfield Management Company, L.p.$151M5.7%15,096,403Added
Vanguard Capital Management LLC$114M4.3%11,364,236Added
Vanguard Portfolio Management LLC$111M4.2%11,139,158Trimmed
TCG Crossover Management, LLC$110M4.2%11,020,968Unchanged
Perceptive Advisors LLC$103M3.9%10,308,888Added
Jupiter Topco LLC$95.3M3.6%9,540,764First report
Vestal Point Capital, LP$83.0M3.1%8,300,000Added
Two Sigma Investments, LP$67.8M2.6%6,775,349Added
Geode Capital Management, LLC$62.5M2.4%6,248,046Added
Aberdeen Group plc$53.1M2.0%5,310,871Added
UBS Group AG$50.8M1.9%5,078,280Added
Bank of America Corp$48.0M1.8%4,801,284Trimmed
Goldman Sachs Group Inc$44.8M1.7%4,481,874Added
Frazier Life Sciences Management, L.P.$40.1M1.5%4,009,240Unchanged
Nuveen, LLC$40.1M1.5%4,007,237Added
Nantahala Capital Management, LLC$38.0M1.4%3,802,320Added
Millennium Management LLC$33.9M1.3%3,394,729Added
GW&K Investment Management, LLC$31.7M1.2%3,171,113Trimmed
Jane Street Group, LLC$27.6M1.0%2,762,683Added
Dimensional Fund Advisors LP$27.2M1.0%2,718,781Added
Fisher Asset Management, LLC$26.0M1.0%2,604,027Trimmed
Renaissance Technologies LLC$25.3M1.0%2,530,290Added

Share of 13F holdings is each fund's shares as a share of the 263,846,834 BCRX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $386M and sold $224M; 131 added and 84 trimmed.

Schedule 13D and 13G filings on BCRX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about BCRX ownership

Who owns BCRX stock?
318 institutional investment managers reported BCRX positions in their Form 13F filings for Q2 2026, holding 263,846,834 shares worth $2.6B in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling BCRX?
In Q2 2026, 54 managers opened new BCRX positions, 131 added, 84 trimmed and 37 sold out. Managers that filed in both quarters added a net 15,679,274 shares.
How current is this BCRX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BCRX by CUSIP. Options are left out. BCRX news and filings · BCRX insider trades · Top funds